Create Free Account

By creating account you will get access to hot stocks & personalised emails

HealthEquity Inc

Healthcare US HQY

94.62USD
3.08(3.36%)

Last update at 2024-12-19T18:55:00Z

Day Range

92.5094.84
LowHigh

52 Week Range

54.2884.49
LowHigh

Fundamentals

  • Previous Close 91.54
  • Market Cap6897.27M
  • Volume638940
  • P/E Ratio123.86
  • Dividend Yield-%
  • EBITDA281.21M
  • Revenue TTM999.59M
  • Revenue Per Share TTM11.68
  • Gross Profit TTM 490.09M
  • Diluted EPS TTM0.64

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-01-31 2022-01-31 2021-01-31 2020-01-31 2019-01-31
Type yearly yearly yearly yearly yearly
Date 2023-01-31 2022-01-31 2021-01-31 2020-01-31 2019-01-31
Income before tax -38.09600M -66.74100M 4.14M 43.16M 75.82M
Minority interest - - - - -
Net income -26.14300M -44.28900M 8.83M 39.66M 73.90M
Selling general administrative 95.63M 84.38M 84.49M 60.56M 33.04M
Selling and marketing expenses 68.85M 58.60M 49.96M 43.95M 29.50M
Gross profit 490.09M 423.71M 415.33M 325.91M 181.19M
Reconciled depreciation 161.20M 137.19M 115.90M 55.35M 18.18M
Ebit 38.92M 34.64M 83.28M 77.01M 77.67M
Ebitda 200.12M 171.82M 199.18M 155.39M 95.86M
Depreciation and amortization 161.20M 137.19M 115.90M 78.38M 18.18M
Non operating income net other - - 5.01M -9.07900M -1.85200M
Operating income 38.92M 34.64M 83.28M 77.01M 77.67M
Other operating expenses 824.10M 715.99M 653.57M 422.88M 209.57M
Interest expense 48.42M 36.57M 34.88M 24.77M 0.00000M
Tax provision -11.95300M -22.45200M -4.69400M 3.49M 1.92M
Interest income 1.76M 1.50M 1.04M 5.91M -
Net interest income -46.66100M -36.57200M -34.88100M -18.86700M -
Extraordinary items - - - - -
Non recurring - - 45.99M 32.11M -
Other items - - - - -
Income tax expense -11.95300M -22.45200M -4.69400M 3.49M 1.92M
Total revenue 861.75M 756.56M 733.57M 531.99M 287.24M
Total operating expenses 452.44M 383.14M 335.33M 216.79M 103.52M
Cost of revenue 371.66M 332.85M 318.24M 206.08M 106.05M
Total other income expense net -77.02000M -101.37700M -79.13800M -33.85100M -1.85200M
Discontinued operations - - - - -
Net income from continuing ops -26.14300M -44.28900M 8.83M 39.66M 73.90M
Net income applicable to common shares -26.14300M -44.28900M 8.83M 39.66M 73.90M
Preferred stock and other adjustments - - - - -
Breakdown 2024-01-31 2023-01-31 2022-01-31 2021-01-31 2020-01-31
Type yearly yearly yearly yearly yearly
Date 2024-01-31 2023-01-31 2022-01-31 2021-01-31 2020-01-31
Total assets 3236.50M 3088.90M 3107.10M 2710.01M 2565.18M
Intangible assets 835.95M 936.36M 973.14M 767.00M 783.28M
Earning assets - - - - -
Other current assets 48.56M 31.79M 38.49M 58.61M 33.79M
Total liab 1201.48M 1193.26M 1254.53M 1331.28M 1534.89M
Total stockholder equity 2035.02M 1895.64M 1852.58M 1378.73M 1030.30M
Deferred long term liab - - 4.40M 5.00M 6.40M
Other current liab 95.65M 89.50M 104.72M 126.15M 96.69M
Common stock 0.00900M 0.00800M 0.00800M 0.00800M 0.00700M
Capital stock 0.00900M 0.00800M 0.00800M 0.00800M 0.00700M
Retained earnings 205.63M 149.92M 176.06M 220.35M 211.51M
Other liab - 95.37M 114.03M 128.54M 133.12M
Good will 1648.14M 1648.14M 1645.84M 1326.79M 1334.13M
Other assets 0.00000M 52.18M 49.81M 37.42M 35.11M
Cash 403.98M 254.27M 225.41M 328.80M 191.73M
Cash and equivalents - - - - -
Total current liabilities 117.09M 131.06M 153.19M 204.30M 152.14M
Current deferred revenue - - - - -
Net debt 529.16M 740.22M 782.82M 746.17M 1109.37M
Short term debt 9.40M 27.66M 20.92M 76.54M 51.46M
Short long term debt - 17.50M 8.75M 62.50M 39.06M
Short long term debt total 933.14M 994.49M 1008.23M 1074.98M 1301.10M
Other stockholder equity 1829.38M 1745.72M 1676.51M 1158.37M 818.77M
Property plant equipment - 69.32M 86.98M 118.61M 33.49M
Total current assets 557.44M 382.89M 351.34M 460.18M 296.00M
Long term investments - - - - -
Net tangible assets - -688.86400M -766.39800M -715.06800M -1085.61500M
Short term investments - - - - -
Net receivables 104.89M 96.83M 87.43M 72.77M 70.48M
Long term debt 874.97M 907.84M 922.08M 924.22M 1181.62M
Inventory - - - - -
Accounts payable 12.04M 13.90M 27.54M 1.61M 3.98M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 0.00000M - - - -15.75700M
Additional paid in capital - - - - -
Common stock total equity - - - 0.00800M 0.00700M
Preferred stock total equity - - - - -
Retained earnings total equity - - - 220.35M 211.51M
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other -768.08000M 52.18M 49.81M 37.42M 35.09M
Deferred long term asset charges - - - - -
Non current assets total 2679.06M 2706.01M 2755.76M 2249.83M 2269.18M
Capital lease obligations 58.17M 69.15M 77.40M 88.26M 80.42M
Long term debt total - - - - 1181.62M
Breakdown 2023-01-31 2022-01-31 2021-01-31 2020-01-31 2019-01-31
Type yearly yearly yearly yearly yearly
Date 2023-01-31 2022-01-31 2021-01-31 2020-01-31 2019-01-31
Investments -119.12700M 2.37M -96.96400M -53.84500M 40.69M
Change to liabilities -26.67300M -2.17800M 30.42M 6.47M 8.33M
Total cashflows from investing activities -119.12700M -639.24700M -96.96400M -1740.49400M 25.65M
Net borrowings -8.75000M -53.12500M -239.06300M 1211.68M 1242.19M
Total cash from financing activities -2.67100M 394.86M 52.42M 1467.74M 22.93M
Change to operating activities 2.87M 15.01M -17.71400M -1.51600M 2.14M
Net income -26.14300M -44.28900M 8.83M 39.66M 73.90M
Change in cash 28.85M -103.38900M 137.08M -169.74900M 162.00M
Begin period cash flow 225.41M 328.80M 191.73M 361.48M 199.47M
End period cash flow 254.27M 225.41M 328.80M 191.73M 361.48M
Total cash from operating activities 150.65M 141.00M 181.62M 105.86M 113.42M
Issuance of capital stock 0.00000M 456.64M 286.78M 458.50M -
Depreciation 161.20M 137.19M 115.90M 55.35M 18.18M
Other cashflows from investing activities - - -83.87100M -1679.36300M -11.17300M
Dividends paid - - - - -
Change to inventory - - -30.42200M -4.10100M -2.28900M
Change to account receivables -9.57000M -11.20400M -0.41300M -6.12700M -4.30600M
Sale purchase of stock - - 295.35M 469.84M 22.93M
Other cashflows from financing activities -0.60300M 941.35M 4.71M 1017.06M 22.93M
Change to netincome 45.70M 42.02M 39.48M 20.36M 21.70M
Capital expenditures 119.13M 137.08M 96.96M 42.07M 15.04M
Change receivables - - -0.41300M -5.00900M -4.30600M
Cash flows other operating - - -18.48500M -11.82500M -5.32000M
Exchange rate changes - - - - -
Cash and cash equivalents changes - - 137.08M -169.74900M 162.00M
Change in working capital -33.37000M 1.62M 12.29M -9.51700M -1.30000M
Stock based compensation 62.61M 52.75M 42.86M 39.84M 21.06M
Other non cash items 3.53M 17.15M 6.86M -23.15100M 1.17M
Free cash flow 31.52M 3.91M 84.66M 63.78M 98.38M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
HQY
HealthEquity Inc		 3.08 3.36% 94.62 123.86 42.37 6.88 3.38 7.41 26.13
GEHC
GE HealthCare Technologies Inc.		 0.62 0.80% 77.71 22.91 20.12 2.01 5.52 2.39 13.30
VEEV
Veeva Systems Inc Class A		 -2.02 0.91% 219.52 54.61 33.22 12.83 6.73 11.14 58.84
MTHRF
M3 Inc		 - -% 9.73 29.72 25.00 0.05 4.38 0.04 0.12
MTHRY
M3 Inc		 -0.13 2.97% 4.25 31.84 26.25 0.05 4.60 0.04 0.12

Reports Covered

Stock Research & News

View All

Profile

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.

HealthEquity Inc

15 West Scenic Pointe Drive, Draper, UT, United States, 84020

Key Executives

Name Title Year Born
Mr. Jon Kessler Pres, CEO & Director 1968
Mr. Tyson Murdock Exec. VP & CFO 1971
Mr. Darcy G. Mott Special Advisor 1953
Mr. Larry L. Trittschuh Exec. VP & Chief Security Officer 1972
Mr. Elimelech Rosner Exec. VP & CTO 1957
Mr. Richard Putnam VP of Investor Relations NA
Mr. Delano Ladd Exec. VP, Gen. Counsel & Sec. 1981
Mr. Steve Lindsay Exec. VP of Sales & Relationship Management NA
Mr. Brad Bennion Sr. VP of Corp. Devel. NA
Ms. Tia Padia Sr. VP of Marketing NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.

Our Company

Useful Links

Contact Us

ISO Certified Market Research

Kalkine Solutions Private Limited, authorized representative of Kalkine Pty Ltd, holds ISO 27001:2022 certification bearing Certificate No.- IC-IS-2404072

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.